Evidence map›Paper›PMID 28347972›Full record

SynthesisJournal of medical Internet research2017

The Effect of Technology-Mediated Diabetes Prevention Interventions on Weight: A Meta-Analysis.

Rachel R Bian, Gretchen A Piatt, Ananda Sen, Melissa A Plegue, Mariana L De Michele, Dina Hafez, Christina M Czuhajewski, Lorraine R Buis, Neal Kaufman, Caroline R Richardson

Abstract readMeta-Analysis
In one paragraph

Synthesis in Journal of medical Internet research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rachel R BianUniversity of Michigan Medical School, Ann Arbor, MI, United States.ORCID 0000-0002-4809-489X
Gretchen A PiattDepartment of Learning Health Sciences, University of Michigan, Ann Arbor, MI, United States.ORCID 0000-0001-6641-6330
Ananda SenUniversity of Michigan, Department of Family Medicine, Ann Arbor, MI, United States.ORCID 0000-0002-9632-6704
Melissa A PlegueUniversity of Michigan, Department of Family Medicine, Ann Arbor, MI, United States.ORCID 0000-0001-6032-534X
Mariana L De MicheleUniversity of Michigan, Department of Internal Medicine, Ann Arbor, MI, United States.ORCID 0000-0002-3891-4436
Dina HafezUniversity of Michigan, Department of Internal Medicine, Ann Arbor, MI, United States.ORCID 0000-0002-2260-0299
Christina M CzuhajewskiUniversity of Michigan, Department of Family Medicine, Ann Arbor, MI, United States.ORCID 0000-0002-3033-9641
Lorraine R BuisUniversity of Michigan, Department of Family Medicine, Ann Arbor, MI, United States.ORCID 0000-0001-5855-9972
Neal KaufmanGeffen School of Medicine and Fielding School of Public Health, Departments of Pediatrics and Public Health, University of California, Los Angeles, CA, United States.ORCID 0000-0002-2202-9547
Caroline R RichardsonUniversity of Michigan, Department of Family Medicine, Ann Arbor, MI, United States.ORCID 0000-0002-1945-6046

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
TRAINING PROGRAM IN ENDOCRINOLOGY AND METABOLISM.T32DK007245 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RICHARD J. AUCHUS · 1986 to 2026
$7.2M
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK092926NIDDK NIH HHS T32 DK007245
6 · The paper itself

Abstract

backgroundLifestyle interventions targeting weight loss, such as those delivered through the Diabetes Prevention Program, reduce the risk of developing type 2 diabetes. Technology-mediated interventions may be an option to help overcome barriers to program delivery, and to disseminate diabetes prevention programs on a larger scale.

objectiveWe conducted a meta-analysis to evaluate the effect of such technology-mediated interventions on weight loss.

methodsIn this meta-analysis, six databases were searched to identify studies reporting weight change that used technology to mediate diet and exercise interventions, and targeted individuals at high risk for developing type 2 diabetes. Studies published between January 1, 2002 and August 4, 2016 were included.

resultsThe search identified 1196 citations. Of those, 15 studies met the inclusion criteria and evaluated 18 technology-mediated intervention arms delivered to a total of 2774 participants. Study duration ranged from 12 weeks to 2 years. A random-effects meta-analysis showed a pooled weight loss effect of 3.76 kilograms (95% CI 2.8-4.7; P<.001) for the interventions. Several studies also reported improved glycemic control following the intervention. The small sample sizes and heterogeneity of the trials precluded an evaluation of which technology-mediated intervention method was most efficacious.

conclusionsTechnology-mediated diabetes prevention programs can result in clinically significant amounts of weight loss, as well as improvements in glycaemia in patients with prediabetes. Due to their potential for large-scale implementation, these interventions will play an important role in the dissemination of diabetes prevention programs.

Indexed as

Biomedical TechnologyBody WeightDiabetes Mellitus, Type 2HumansWeight Lossdiabetes mellitus, type 2meta-analysisprediabetic statetechnologyweight reduction programs

Identifiers

PMID28347972
PMCPMC5387112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.